Sanghyo Park
Overview
Explore the profile of Sanghyo Park including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
39
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Park S, Lee W
Biodivers Data J
. 2024 Nov;
12:e134165.
PMID: 39544626
Background: The tribe Tropidocephalini is the second largest tribe of the subfamily Delphacinae, comprising 204 species of 37 genera worldwide. Most species in this tribe feed on bamboo (Bambusoideae) or...
2.
Aryal S, Park S, Cho H, Choi K, Choi M, Park Y, et al.
Biomed Eng Lett
. 2024 Sep;
14(5):1113-1124.
PMID: 39220034
Supplementary Information: The online version contains supplementary material available at 10.1007/s13534-024-00396-x.
3.
De Giorgi A, Bellussi F, Parlani S, Lucisano A, Silvestri E, Aryal S, et al.
J Mol Model
. 2024 Jun;
30(7):219.
PMID: 38896158
Context: The rapid growth and diversification of drug delivery systems have been significantly supported by advancements in micro- and nano-technologies, alongside the adoption of biodegradable polymeric materials like poly(lactic-co-glycolic acid)...
4.
Aryal S, Park S, Park H, Park C, Kim W, Thakur D, et al.
Int J Nanomedicine
. 2023 Dec;
18:7865-7888.
PMID: 38146467
Lung cancer is one of the most common malignant tumors worldwide and is characterized by high morbidity and mortality rates and a poor prognosis. It is the leading cause of...
5.
Park S, Park H, Park C, Yun W, Hwang S, Yoon H, et al.
Biomater Sci
. 2022 Jul;
10(15):4335-4344.
PMID: 35775589
Despite advances in cancer therapy, the discovery of effective cancer treatments remains challenging. In this study, a simple method was developed to increase the efficiency of doxorubicin (DOX) delivery in...
6.
Choi S, Lee S, Park S, Park S, Park C, Key J
Yonsei Med J
. 2021 Oct;
62(11):1042-1051.
PMID: 34672138
Purpose: Indocyanine green (ICG) is a promising agent for intraoperative visualization of tumor tissues and sentinel lymph nodes in early-stage gynecological cancer. However, it has some limitations, including a short...
7.
Aryal S, Park S, Park C, Choi M, Key J
Artif Cells Nanomed Biotechnol
. 2021 Apr;
49(1):390-396.
PMID: 33847187
Curcumin has great potential in cancer treatment and prevention. However, free curcumin for anticancer effect is limited due to its low water solubility and instability. Delivery of free curcumin using...
8.
Park J, Chu G, Park S, Park C, Aryal S, Kang W, et al.
Pharmaceutics
. 2020 Aug;
12(8).
PMID: 32781576
Curcumin is considered a potential anti-asthmatic agent owing to its anti-inflammatory properties. The objective of the present study was to prepare curcumin-containing poly(lactic--glycolic acid)-based microscale discoidal polymeric particles (Cur-PLGA-DPPs) and...
9.
Park J, Park S, Lee T, Hwang Y, Kim J, Kang W, et al.
Biomaterials
. 2019 Jul;
218:119331.
PMID: 31299455
Various types of particle-based drug delivery systems have been explored for the treatment of pulmonary diseases; however, bio-distribution and elimination of the particles should be monitored for better understanding of...
10.
Nguyen T, Aryal S, Pitchaimani A, Park S, Key J, Aryal S
Nanomedicine
. 2018 Dec;
16:79-87.
PMID: 30529792
The rationale for the design of drug delivery nanoparticles is traditionally based on co-solvent self-assembly following bottom-up approaches or in combination with top-down approaches leading to tailored physiochemical properties to...